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Abstract
Introduction Parkinson’s disease (PD) can influence the function of respiration, pho‐
nation and articulation, quality of speech, swallowing, salivation, and graphomotor 
skills.
Aim and methodology: This chapter is based on research of the degree of impairments 
of speech, phonation, salivation, swallowing, and handwriting in 64 patients with PD. 
The results of maximal phonation time (MPT) were compared with two control groups 
of healthy young (N = 35) and healthy elderly (N = 35) subjects. The degree of impairment 
of these functions was measured by the Unified Parkinson Disease Rating Scale (UPDRS) 
subtests.
Results and discussion: In the group with PD, speech impairments of various degrees 
were present in 82.81% of patients. The problem of salivation control of different degrees 
was present in 68.75% of the sample. Swallowing difficulty of different degrees was 
present in 53.15% of the sample. Difficulty writing of various degrees had 84.38% of the 
sample. The average MPT in group with PD was 11.61 s, 21.39 s in the group of healthy 
young, and 20.52 in the group of healthy elderly subjects.
Conclusion: Patients with PD on subtests UPDRS had various degrees of damages to the 
functions. Patients with PD had significantly shorter MPT than the control group.
Keywords: Parkinson’s disease, speech impairments, dysarthria, phonation, maximum 
phonation time, salivation, dysphagia, swallowing, handwriting
1. Introduction
Parkinson’s disease (PD) follows Alzheimer’s disease on the list of most common neurode‐
generative diseases and affects approximately 6.3 million people worldwide [1].
© 2017 The Author(s). Licensee InTech. This chapt r is distributed under the terms of the Creative Comm s
Attribution L cense (http://creativecommons. /licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Approximately 89% of people worldwide with idiopathic PD have disordered communi‐
cation [2], and approximately 90% of individuals with idiopathic PD develop hypokinetic 
dysarthria [3, 4]. The disease is caused by pathoanatomical and physiological changes in 
the brain cells. The changes are manifested by a significant reduction in the concentration 
of dopamine in the basal ganglia as a result of degeneration of nigrostriatal dopaminergic 
neurons.
James Parkinson was the first to define the manifestation of “shaking palsy” two centuries ago 
[5]. In 1912, Fritz Heinrich Lewy identified the abnormal inclusions in nerve cell bodies in 25 
Parkinson’s patients [6]. Carlsson et all discovered that dopamine was a putative neurotrans‐
mitter [7]. The Nobel Prize in Medicine was awarded to Arvid Carlsson, Paul Greengard, and 
Eric R. Kandel in 2000 for their discoveries concerning the role of dopamine in signal trans‐
duction in the nervous system [8].
When the disease is diagnosed, approximately 70% striatum dopamine has already been 
depleted and it advances in time [9]. In the advanced stage of PD, most of the dopaminergic 
neurons are lost, concomitant with significant cell death during the process [10]. PD is still 
diagnosed based on clinical observations. The acronym TRAP is used for the four major 
signs of PD and it stands for tremor at rest, rigidity, akinesia (bradykinesia), and postural 
instability [11]. These signs of the disease are associated with primary motor symptoms, 
including dynamic gait, micrographia, and others. Besides the motor symptoms, there are 
equally important non‐motor symptoms such as cognitive impairment, apathy, sleep dis‐
orders, and so on. The most widely used tool nowadays is the Unified Parkinson’s Disease 
Rating Scale (UPDRS) for clinical observation, which was introduced in 1987 and is currently 
awaiting revision [12, 13].
Parkinson’s disease can influence the function of respiration, phonation, articulation, swal‐
lowing, salivation, and graphomotor skills. Damage to these functions has resulted in the 
occurrence of variations in the quality of voice and speech.
Phonation, prosody, and articulation are the three main speech components altered in PD. 
These changes are grouped under the term “hypokinetic dysarthria.” Vowel production, an 
important aspect of speech for intelligibility, is commonly altered in PD [14].
The simplest examination functions of the glottides in phonation is to determine the maxi‐
mum duration of vowel phonation after the previous deepest possible inspirium. If the pho‐
nation is shorter than 15 s, this happens for two reasons: either vocal cords in phonation 
are damaged, that is, dysfunctional, or the vital capacity is reduced [15, 16]. Shortening the 
maximum length of phonation in patients with PD is a consequence of failure of respiratory 
muscles and reduced vital capacity. There are also glottal insufficiency functions to further 
reduce the length of phonation.
Maximal phonation time (MPT) is in practice in the area of Serbian‐speaking language is 
rarely used for verification and diagnostic quantitative skills phonation patients with PD. It is 
impossible to know that the MPT is used as a routine method in the diagnosis of patients with 
PD with other spoken languages. We could not find information about it from the available 
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literature. The introduction of MPT as one of the routine quantitative methods can be supple‐
mented by information about the levels of damage or progression of PD.
Speech disorders in Parkinson disease result from the disorder
• Disorders of the respiratory function due to the weakening of respiratory muscles. Insuf‐
ficient amount of air inhaled; small expiratory volume in expiratory stage. The patient is 
forced to interrupted speech due to the difficulty in breathing. The rhythm of breathing is 
disturbed due to uncoordinated movements of muscles involved in breathing.
• The respiratory insufficiency results in reduced pulmonary ventilation and increased 
accumulation of secretions in the airways. Accumulated secretions in the airways are 
insufficiently pushed out of the body. It represents a good basis for the development of 
microorganisms and infection as a result of weaker ventilation of lungs. Frequent respira‐
tory infections are the cause of cardiorespiratory complications, deterioration of general 
condition of the body, and difficulty in speech communications.
• Some patients had poor controlling functions of the vocal cords which resulted in uncontrolled 
outflow of air currents. In the advanced stage of disease, hypophonia or aphonia occurred 
due to vocal cord dysfunction, which further reduced the intelligibility of communication.
• The articulation of a large number of sounds is unclear because of the imprecision of articu‐
lation movements, especially the votes requiring a wide mandible angle (a, o, l, r, k, and g). 
The quality of pronunciation is poorer with voices that require a coordinated movement of 
several groups of articulator muscles.
• Phonation is very short due to a very short, insufficient expiration. The patient cannot pro‐
nounce words with more syllables, as well as short and long sentences without interruption.
• The strength of the voice is not sufficient for good understanding of the voice message. 
At the beginning of the sentence, the patient is loud and clear. The patient accelerates the 
speech tempo if the voice message is long. The intensity of the voice decreases. The sounds 
are superficial and unclear, while the speech becomes less intelligible. In some patients, the 
speech is monotonous, without modulation or intonation.
• In some patients, the result is a nasal tone, because the soft palate motion is damaged.
Savić et al. investigated the degree of impairments of speech, salivation, swallowing, and 
writing in 64 patients with PD. In particular, they examined the ability and length of the maxi‐
mal phonation time of the vowel /a/ in those patients. These results were compared with two 
control groups of 35 healthy young and 35 healthy elderly subjects [17].
The degree of impairment of the speech, salivation, swallowing, and writing function in 
patients with PD is estimated with self‐evaluation in the part of the Unified Parkinson’s 
Disease Rating Scale—Activities of Daily Living. UPDRS (Unified Parkinson’s Disease Rating 
Scale) is a scale consisting of three different groups of issues related to the mental state—
mood, behavior, ability to perform activities of daily living, and motor activity. The  maximum 
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score that can be achieved in UPDRS is 199, which also represents the most severe form of 
disability due to disease.
The authors registered the data of speech, salivation, swallowing, and handwriting during 
self‐evaluation at the beginning of the rehabilitation for the patients examined. It was possible 
to get 0–16 points for the four variables. It was possible to score 0–4 points for each separate 
variable. At the same time, 0 points means normal function, 1, mildly affected, 2, moderately 
affected, 3, severely affected, and 4, no observed features. Score of 16 points means total dis‐
ability for all four examined variables.
The authors measured the value of the maximum length of phonation of the vowel /a/ for each 
separate category of the respondents. They calculated the average TMP for each group of the 
subjects based on the average TMP of each patient. The average scores of MPT for each group 
of respondents were compared with each other.
In patients with PD, the ability to control and coordinate fine movements of the hand is reduced 
or completely lost due to the presence of a neurological damage. There is often a different degree 
of the impairment of previously acquired skills of writing as a result of a neurological damage. 
The graphomotor movements are insecure and of a limited amplitude, resulting in a small and 
shaky handwriting (extrapyramidal micrograph). The letters become tortuous and blade‐like 
teeth (“sawtooth” writing), which is caused by the tremor and rigor of finger arm muscles.
In the context of non‐motor manifestations of PD, drooling is defined as an excessive amount 
of saliva in the mouth, which is especially intensified in the later stages [18]. At present, the 
pathophysiology of drooling in PD is not completely clear; however, impaired intraoral sali‐
vary clearance is likely to be the major factor. There are neither standard diagnostic criteria 
nor standard severity assessment tools for evaluating drooling in PD. In accordance with the 
possible pathophysiology, dopaminergic agents have been used to improve salivary clear‐
ance; however, these agents are not completely effective in drooling control [19].
Sialorrhea may be higher in PD. Sialorrhea defined as an overflow of saliva from the mouth 
(drooling) and negatively affects both patient’s quality of life and social interactions [20, 21]. 
Its etiology includes acute and chronic neurological disorders (such as PD), hypersecretion 
(inflammatory processes in oral cavity), adverse effects of some drugs, or anatomic abnor‐
malities affecting oral cavity [22].
In PD patients, saliva is associated with swallowing problems in 46.5% of patients who com‐
plained about the drooling, the saliva, or spills, 18.8% of whom thought their saliva was 
socially disabling [23]. When a PD patient spills out saliva, it is associated with swallow‐
ing problems and posture, characteristic of these patients [24]. More than 80% of patients 
with Parkinson’s disease develop dysphagia during the course of their disease. Swallowing 
impairment reduces quality of life, complicates medication intake, and leads to malnutrition 
and aspiration pneumonia, which is a major cause of death in PD [25].
Dysphagia affects approximately 33% of all patients diagnosed with Parkinson’s disease, 
although other prevalent studies highlight dysphagic effects noticeable in a broad range of 
PD patients from 45 to 90% [26].
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2. Speech impairment, phonation, writing, salivation, and swallowing
2.1. Age, gender, and educational level of the sample and duration of the disease
The way PD influences the occurrence of voice disorders, impairments of phonation, hand‐
writing, salivation, and swallowing can be seen from the results of research by Savićet al. on a 
sample of 64 patients with PD [17].
In this research, the average age of patients with PD was 70.65 years. The age of patients ranged 
from 45 to 85 years. The average age of the group of healthy elderly respondents was approxi‐
mately similar. The average age of patients in this group was 70.20.
The average age of the group of healthy young subjects was 24.14. The students were the 
largest part of the group of healthy young subjects. Respondents of both control groups 
had the value of certain parameters of speech and language status within the normal limits 
in relation to the quality of voice, speech, and language in the Serbian language. We took 
as a control group of healthy young people, because we thought that we would have a 
greater difference between the variable MPT healthy young and healthy elderly subjects. 
You will see in the text that follows that the difference MPT of these two groups is small. 
The answer to the question: Is it a consequence of less physical activity of young people, 
prolonged sitting in front of computer and physical inactivity young we’ll search in some 
future study.
Most patients (29) with PD had elementary education. Twenty‐eight respondents had high 
school, four respondents had the undergraduate level of education, and three respondents 
had higher education (university degree). The education level of patients with PD, and the 
frequent use of speech in the profession and the frequent use of writing could affect at some 
of the observed variables of the study (on the phonation and writing). It is not the same speech 
ability of a professional speaker and a poorly educated man. This could be one of our future 
researches because we have limited space for this chapter. The age and gender structure of 
patients with PD are shown in Figure 1.
The assessment of status of the patients with UPDRS subtests was performed after the aver‐
age of 57.90 (±5.60) months from the occurrence of the first signs of disease (Figure 2).
2.2. Speech impairment
This was present in 53 patients (82.81%) in the group with PD (Figure 3). It is approximately 
similar to the findings of Fox et al., Muller et al., and Duffy [2–4]. There was no significant 
impairment of the quality of voice, speech, and language in 11 patients (17.18%). In the group 
of patients with speech impairments, speech was mildly damaged in 41 (64.06%), moderately 
damaged in 8 (12.50%), and severely damaged in 4 (5.25%) patients. There were no patients 
with totally incomprehensible speech (Figure 3).
The results showed that all patients with PD had different degrees of damage to some of 
the examined functions. The maximum phonation time in patients with PD was significantly 
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shorter than in the control groups. They had impairments of the quality of the voice and 
speech characteristics. The results showed that the speech of different degrees of impairments 
was present in 82.81% of patients in the group with PD (Figure 3).
The average MPT in PD patients without speech impairments was 15.73 s. In PD patients with 
speech impairments, it was 10.75 s. The group of young healthy subjects had the average MPT 
of 21.39 s, and MPT of the group of healthy elderly subjects was 20.52 s. MPT of patients with 
PD was measured only at the beginning of rehabilitation.
Figure 1. Age and gender of patients with PD in the examined sample.
Figure 2. The onset of the first PD signs by the N of months.
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The average maximum length of the vowel /a/ phonation in all patients with PD was 11.61 s 
(±6.33) ranging from 1.33 to 29.66 s (Figure 4). In patients with PD, the presence was indicated 
of a large range of MPT values. This shows that in patients with PD functions of respiration 
Speech
 
12.50%  
64.06%  
17.18%  
Severely affected
 
Moderately affected  
Mildly affected  
Normal
 
6.25%
 
Figure 3. The degree of speech impairments in patients with PD. Speech: 0, normal; 1, mildly affected, but no difficulty 
being understood; 2, moderately affected, sometimes asked to repeat statements; 3, severely affected, frequently asked 
to repeat statements; and 4, unintelligible most of the time (patients with this level impairments were not in the sample).
Figure 4. Maximum phonation time in some groups of tested samples.
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and phonation were not equally damaged, which directly affected the TMP result. For exam‐
ple, a patient who had MPT of 29.66 s had both of these functions well preserved. The patient 
was a logger by profession. His profession demanded a great physical effort. He had well‐
developed functions of respiration and phonation. These people generally have higher inten‐
sity of vocalization because they work in noisy environment. They have to speak louder to be 
able to communicate because of the noise of chainsaws. Based on his results achieved in the 
testing MPT, we can conclude that both these functions remain preserved or slightly impaired.
It was found that the correlation of the time of first PD symptoms occurrence and the average 
length of phonation was r = 0.264; p = 0.035. This means that the duration of the disease onset 
did not have such a great impact on the MPT in all patients’ sample. Some patients had the 
compromised function of limbs, walk, posture, balance, swallowing, writing, and so on. In a 
part of this group, the damage reflected on phonation and speech.
Whether the disruption of phonation length is severe or minor will depend on the neurologi‐
cal damage to the respiratory function or damage to the vocal cords or both functions.
In the group of PD patients whose MPT was up to 10 s, there were 32 patients or 50% of the 
sample. The average MPT of this group was 6.98 s; 28 patients in this group had speech prob‐
lems, whereas only 4 of them were without speech difficulties.
In the group of patients with PD whose MPT was from 11 to 20 s, there were 24 patients, or 
37.50% of the sample. The average MPT of this group was 13.37 s. Only two patients in this 
group did not have any speech problems.
In the group of patients with PD whose MPT was over 20 s, there were eight patients or 
12.50% of the sample. The average MPT of this group was 24.87 s. Only three patients in this 
group had a speech difficulty, and the remaining five did not have speech problems.
The correlation between the total results of the UPRDS variables measured and the average 
length of phonation results of the sound /a/ was r = 0.506; p = 0.000.
Bauer et al. [27] found that in the group of 21 patients with PD and analogous group of healthy 
people, there was significant difference in the maximum phonation time which was shorter in 
PD group (15.8 and 23 s, p = 0.014).
The average MPT in the group of healthy young subjects was 21.39 s. The average MPT in 
the healthy elderly subjects was 20.52 s. The results did not agree with the research data by 
Hedever et al. [28]. The results were in accordance with the findings by Maslan et al. and 
http://www.foni.mef.hr/Prirucnik/Fonijatrija.htm [15, 16].
Patients with PD without speech impairments had MPT length of 15.73 s. Patients with mildly 
affected speech had MPT of 12.37 s, those with moderately affected speech had 5.49 sec, and 
those with severely affected speech had 4.70 s. There were no patients with unintelligible speech.
In patients with speech impairments from the group with PD, we can see that the length of 
phonation was proportionate to the degree of speech defects. The patients with lower MPT had 
speech impairment, and patients with greater MPT had less severe speech impairment. The 
length and quality of voice affected the quality of the speech and influenced the degree of speech 
damage. The statistical significance of differences in MPT between groups with PD and young 
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healthy subjects was p = 0.000, in patients with PD and healthy elderly subjects it was p = 0.000. 
The statistical significance of differences in MPT between groups with different degrees of 
speech impairments in groups with PD (with and without speech impairments) was p = 0.088.
Short MPT is a sign that the respiratory function is insufficient. This leads to the conclusion 
that it is necessary to work on improving this function to improve the MPT. This prevents 
the occurrence of secondary complications of poor pulmonary ventilation (respiratory and 
cardiovascular complications).
MPT values during treatment of and rehabilitation from PD can be used as a predictive indi‐
cator of the disease progression rate.
Buzadžija and Savić found that patients with PD who had poor MPT results after the inclu‐
sion in rehabilitation also had poor recovery of ability of daily living activities. Daily living 
activities were measured with Barthel index at the beginning and the end of rehabilitation in 
79 patients with PD. Patients were included in the rehabilitation for 3 weeks [29]. The rehabili‐
tation was multidisciplinary. The rehabilitation process involved a doctor specialist physical 
and rehabilitation medicine, physical therapist, occupational therapist, speech therapist in 
patients with present speech impairments, a psychologist in patients with present mental 
disorders, and social worker.
A sample was classified into four groups. The first group patients with PD had Barthel index 
values below 25 at the beginning of rehabilitation. Assessment of the Barthel index has been 
found that the patients with PD had an average score of 11.40 (±8.98) points at the beginning 
and 16.20 (±12.25) points at the end of the rehabilitation. This group of patients had an average 
of MPT 4.73 (±3.39) s.
The second group of patients with PD had Barthel index of 26–50. This group of patients had 
an average score at Barthel index of 41.75 (±5.50) points at the beginning, and 48.25 (±6.70) 
points at the end of rehabilitation. This group of patients had an average of MPT 11.74 s. 
Barthel index of 50 points and less to the beginning of the rehabilitation had nine patients. Of 
these, seven had an average value of MPT from 0 to 10 s (Table 1).
A third group of patients with PD had Barthel index of 51–75 points (Table 1). A third group 
of patients had an average score at Barthel index of 65.33 (±7.25) points at the beginning and 
74.88 (±8.06) points at the end of rehabilitation. This group of patients had an average score 
of MPT 11.98 (±5.71) s. About two‐third of the sample was in this group of patients. In this 
group, 44.44% of patients had values of MPT 0–10 s (Table 1).
The fourth group of patients with PD had Barthel index of 76–100 points. This group of 
patients had an average score of 80.18 (±3.91) points at Barthel index at the beginning and 
85.37 (±6.58) points at the end of rehabilitation. This group of patients had an average score 
of MPT 15.83 (±8.14) s. Majority of patients with lower achievement in the MPT had lower 
achievement on tests of activities of daily living [29].
According to analysis of the findings, 22 patients, or 27.84% of the sample, had 60 points 
or less in Barthel index at the beginning of the rehabilitation. These patients were totally or 
partially dependent on other persons’ help and assistance. Fifty patients (63.29%) had Barthel 
index value ranging 61–80 of the sample. These patients were classified in the category of 
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Value of 
MPT before 
rehabilitation
Value of Barthel index of patients with PD at before and after rehabilitation Total N of the 
patients
N with result 
0–25 points 
before reh.
N with result 
0–25 points 
after reh.
N with result 
26–50 points 
before reh.
N with result 
26–50 points 
after reh.
N with result 
51–75 points 
before reh.
N with result 
51–75 points 
after reh.
N with result 
76–100 points 
before reh.
N with result 
76–100 points 
after reh..
0–10 s 5 4 2 2 24 11 5 19 36
11–20 s 0 ‐ 1 1 24 11 6 19 31
≤21 s 0 ‐ 1 ‐ 6 3 5 9 12
Total 5 4 4 3 54 25 16 47 79
Table 1. The relation between results for MPT and results of Barthel Index at before and after rehabilitation (reh.).
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moderate dependent on other persons’ aid and assistance. At the end of rehabilitation, totally 
or partially dependent on other persons’ aid and assistance, with the Barthel index of 60 
points or less were 12 patients, or 15.18% tested sample. In values ranging 61–80 points of the 
Barthel index, in the category of moderate depending on other persons’ aid and assistance 
were 45 patients, or 56.96% of the tested sample. Only nine out of 79 patients with PD had 80 
or more points at the beginning of the rehabilitation. At the end of rehabilitation, 28 patients 
had Barthel index value of 80 or more points. Out of those, 11 patients had MPT score ranging 
from 6.33 to 10.00 s, 12 patients had scores ranging 11–20 s, and five had MPT of over 20 s.
2.3. Problems affecting the motor skills and muscles of fingers and hands (tremor and 
rigidity), which affect graphomotor and handwriting ability
Motor blocks of fingers, muscles, and hands affect PD patients’ ability to write. Motor blocks 
are related to transient periods in which the intended supple motor activities become a short 
pause [30–32]. Motor blocks extend the classic signs of PD, such as akinesia, bradykinesia, 
rigidity, tremor, and disorders of the postural mechanisms [30]. It manifests in 32 [32] to 60% 
[33] of persons with PD.
In patients with PD, there is a temporary, involuntary inability to move a hand. “Freezing” refers 
to transient periods in which the voluntary motor activity attempted by an individual is paused. 
It is a sudden, unplanned state of immobility that appears to arise from deficits to initiate or 
simultaneously and sequentially execute movements, as well as to correct or plan them [34].
Savić et al. found that the damage to the handwriting of various degrees was present in 84.38% 
of patients with PD (Figure 5). They found 10 patients (15.62%) without difficulty handwriting 
in the tested group of 64 patients. Slightly slow writing was present in 14 (21.87%) patients. 
Moderately slow writing with legible handwriting was present in 19 (29.68%) patients, while 
severely impaired writing with the emergence of poorly legible words was present in eight 
(12.50%) patients. In 13 (20.31%) patients, the most commonly written word was not legible. The 
average UPRDS value for all measured items (speech, salivation, swallowing, and handwriting) 
for patients with PD was 5.09 (±2.60) of the maximum of 16 points. The correlation between the 
length of time from the PD onset and the overall UPRDS results was r = 0.292; p = 0.019 [17].
2.4. Sialorrhea (drooling or excessive salivation)
It is a common problem in neurologically impaired adults who suffer from Parkinson’s 
disease or have had a stroke. Sialorrhea is usually caused by neuromuscular dysfunction, 
hypersecretion, sensory dysfunction, or anatomic (motor) dysfunction. It is most commonly 
caused by poor oral and facial muscle control. Contributing factors may include hyperse‐
cretion of saliva, dental malocclusion, postural problems, and inability to recognize salivary 
spill. Sialorrhea causes a range of physical and psychosocial complications, including perioral 
chapping, dehydration, odor, and social stigmatization, all of which can be devastating for 
patients and their families. The treatment of sialorrhea is best managed by a clinical team 
that includes primary health‐care providers, speech pathologists, occupational therapists, 
dentists, orthodontists, neurologists, and otolaryngologists. Treatment options range from 
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 conservative (i.e., observation, postural changes, and biofeedback) to more aggressive mea‐
sures such as medication, radiation, and surgical therapy [35].
Savić, et al. found that the problem of excessive salivation of different degrees was present in 
68.75% of PD patients (Figure 6).
2.5. Dysphagia
This occurs in a part of patients with PD. Dysphagia can lead to significant deterioration of 
health and quality of life. Of particular concern is the associated risk of aspiration or ingestion 
of foreign particles into the airway, a potential cause of aspiration pneumonia resulting in 
high morbidity and mortality [36, 37].
Studies suggest that 40% of adults aged 60 and older have dysphagia [38, 39]. Stina [40] inves‐
tigated the connection between swallowing functions and quality of life in patients with PD. 
The results showed that high levels of swallowing affected the quality of life. There were 
significant correlations between disease duration and some SWAL‐QOL parameters (correlate 
Swallowing Quality of Life) as well as some of the results of the fiber endoscopic evaluation.
Aspiration pneumonia is often the leading cause of death in persons with neurodegenerative 
diseases, including Parkinson’s disease [41–45]. Patients affected by PD should be aware of 
and closely monitor all increased coughing episodes or a negative alteration of voice quality, 
as these may be early symptoms of dysphagia [46].
Savić, et al. found the present swallowing difficulty of different degrees in 53.15% of PD 
patients [17]. Without swallowing impairments were 30 (46.85%) patients. With more 18 
(28.12%) patients had rare swallowing problems; the occasional swallowing difficulty 
Figure 5. The degree of writing impairments in patients with PD. Handwriting: 0, normal; 1, slightly slow or small; 2, 
moderately slow or small—all words are legible; 3, severely affected, not all words are legible; and 4, the majority of 
words are not legible.
Advances in Speech-language Pathology176
had 14 (21.87%) patients, and swallowing difficulties which required the use of pureed 
food had two (3.12%) patients. There were no patients with the applied nasogastric tube 
or gastrostomy feeding (Figure 7). Analyzing the relation of the average MPT with the 
degree of swallowing impairments, the authors have found that the group of patients 
Figure 6. The degrees of present excessive salivation of patients with PD. Salivation: 0, normal; 1, slight but definite 
excess of saliva in mouth, may have nighttime drooling; 2, moderately excessive saliva, may have minimal drooling; 3, 
marked excess of saliva with some drooling; and 4, marked drooling, requires constant tissue or handkerchief (patients 
with this level impairments were not in the sample).
Figure 7. The degree of swallowing impairments in patients with PD. Swallowing: 0, normal; 1, rare choking; 2, 
occasional choking; 3, requires soft food; and 4, requires nasogastric tube or gastrostomy feeding (patients with this 
level impairments were not in the sample).
Speech Impairment, Phonation, Writing, Salivation, and Swallowing in Patients with Parkinson’s Disease
http://dx.doi.org/10.5772/intechopen.69711
177
from the group 0 (Normal swallowing) had an average of MPT 13.00 s (±6.88). Group 1 
(rare choking) had an average MPT of 12.71 s (±5.88). Group 2 (occasional choking) had 
an average MPT of 8.51 s (±3.72). Group 3 (requires soft food) had an average MPT of 2.41 
s (±1.64). Weaker MPT results were associated with a higher degree of damages to swal‐
lowing function.
The higher the degree of swallowing function deterioration, the lower the MPT value. All 
patients with PD, measured in different UPDRS subsets, had some of the functions damaged.
3. Conclusion
The largest part of the sample with PD had speech impairments. The MPT in patients with PD 
was significantly shorter compared with the healthy people. This had an impact on the quality 
of the voice and speech characteristics of patients with PD.
MPT value can be used as an indicator of the degree of respiratory function impairment. 
Improving these functions during rehabilitation can improve voice and speech quality, but 
also prevent the development of complications as a result of poor pulmonary ventilation. The 
values of MPT in certain phases of treatment and rehabilitation of PD can be used as a prog‐
nostic indicator of the disease progression rate. The damage to the handwriting of various 
degrees was present in 84.38% of patients with PD. Over two‐thirds of patients with PD had 
the problem of excessive salivation of different degrees. More than a half of patients with PD 
had different degrees of swallowing difficulties.
All patients with PD in the measured UPDRS variables had different degrees of damages to 
some of the functions. Functional testing of phonation, speaking, handwriting, salivation, and 
swallowing can be used as diagnostic and prognostic sign of severity of the disease in patients 
with PD.
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